Search Within

Sloan Kettering Institute Postdocs

Formats
  1. Journal Article (7948)
  2. Meeting Abstract (3666)
  3. Review (621)
  4. Editorial (258)
  5. Book Section (191)
  6. Conference Paper (161)
  7. Research Letter (139)
  8. Correspondence (64)
  9. Miscellaneous (63)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. GSK Faculty (6309)
  2. Department of Medicine (4754)
  3. Sloan Kettering Institute Faculty (3537)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (3003)
  5. Surgery (2590)
  6. Solid Tumor Oncology Division (2573)

More Groups

People
  1. Britta Weigelt (374)
  2. Jorge Reis-Filho (328)
  3. Mithat Gonen (313)
  4. Marc Ladanyi (308)
  5. Michael Berger (281)
  6. Joseph Deasy (280)

More People

Years
  1. 2025 (568)
  2. 2024 (1077)
  3. 2023 (1151)
  4. 2022 (1364)
  5. 2021 (1176)
  6. 2020 (1240)

More Years

Publications
  1. Blood (680)
  2. Cancer Research (542)
  3. Journal of Clinical Oncology (431)
  4. Journal of Nuclear Medicine (264)
  5. Annals of Surgical Oncology (258)
  6. Clinical Cancer Research (238)

More Publications

Publishers
  1. Nature Publishing Group (1333)
  2. Elsevier Inc. (1187)
  3. American Association for Cancer Research (1045)
  4. Springer (827)
  5. American Society of Hematology (737)
  6. Cell Press (737)

More Publishers

Results (13147)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic characterization and classification of BCL6 rearranged follicular lymphomas
    Meeting Abstract

    Amallraja, A.; Gundem, G.; Domenico, D.; Ossa, J. E. A.; Aypar, U.; Baik, J.; Kluk, M.; Sethi, S.; Lopez, K.; Qualls, D. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • High grade B-cell lymphoma with MYC/BCL6-rearrangements (R) may have inferior outcomes compared to BCL2-R disease
    Meeting Abstract

    Healton, S. E.; Luttwak, E.; Rivas-Delgado, A.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Hamlin, P. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Systematic evaluation of GAPs and GEFs identifies ARHGAP45 as a targetable leukemia-specific dependency
    Meeting Abstract

    Zhang, P.; Cao, Z.; Pan, X.; Liu, Y.; Castro, C.; Kim, W. J.; Fujino, T.; Lewis, J.; Rahman, J.; Shahid, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Immune-MRD status informs tumor-MRD outcome prognostication in multiple myeloma patients on lenalidomide maintenance
    Meeting Abstract

    Firestone, R. S.; Simhal, A. K.; McAvoy, D.; Jurgens, E. M.; Garcés, J. J.; Nemirovsky, D.; Derkach, A.; Maclachlan, K. H.; Hultcrantz, M.; Mailankody, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A high-fiber dietary intervention (NUTRIVENTION) in precursor plasma cell disorders improves biomarkers of disease and may delay progression to myeloma
    Meeting Abstract

    Shah, U. A.; Cogrossi, L. L.; Derkach, A.; Castro, F.; Fei, T.; DeWolf, S.; Garces, J. J.; Policastro, A.; Grioni, M.; Sisti, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Cross-talk between leukemic blasts and T cells drives targetable T cell dysfunction in the AML tumor microenvironment
    Meeting Abstract

    DeWolf, S.; Ceglia, N.; Zatzman, M.; Gipson, B.; Elhanati, Y.; Katsamakis, Z.; Lees, H.; Weis, K.; Yepes, G.; Oliveira, B.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • RBMX regulates YTHDC1 nuclear condensates to promote nascent transcription in acute myeloid leukemia
    Meeting Abstract

    Wakiro, I.; Huang, Y.; Yang, X.; Xie, X.; Luo, H.; Chang, K.; Pierson, A.; Batchelor, E.; Cheng, Y.; Nguyen, D. T. T.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Pembrolizumab maintenance instead of autologous hematopoietic cell transplantation for patients with relapsed or refractory Hodgkin lymphoma in complete response after pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin
    Meeting Abstract

    Moskowitz, A.; Shah, G. L.; Ganesan, N.; Chang, T.; Drill, E.; Davey, T.; Hancock, H.; Munayirji, B.; Douglas, M.; Santarosa, A. M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Prognostication and treatment-related outcomes in secondary central nervous system involvement of large B-cell lymphoma (SCNSL): Evidence from a large international cohort
    Meeting Abstract

    Alderuccio, J. P.; Khwaja, J.; Han, S.; Ghione, P.; Nizamuddin, I. A.; Saha, A.; Dong, N.; Wang, Y.; Cherng, H. J. J.; Tolu, S. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • ABBV-383 plus daratumumab-dexamethasone in relapsed or refractory multiple myeloma: A phase 1b dose-escalation and safety expansion study
    Meeting Abstract

    Rodriguez, C.; Mielnik, M.; Kazandjian, D.; Janowski, W.; Low, M. S. Y.; Pianko, M.; Yuda, J.; Van Der Weyden, C.; Anderson, L. D. Jr; Banerjee, R.; more...
    Blood (2024)

    Fulltext@MSK | Save